Article
Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment.
Journal of cellular and molecular medicine - 1 Mar 2009
Hrstka Roman, Coates Philip J, Vojtesek Borivoj
Abstract excerpt
The p53 tumour suppressor protein lies at the crossroads of multiple cellular response pathways that control the fate of the cell in response to endogenous or exogenous stresses and inactivation of the p53 tumour suppressor signalling pathway is seen in most human cancers. Such aberrant p53 activity may be caused by mutations in the TP53 gene sequence producing truncated or inactive mutant proteins, or by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
